BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15890007)

  • 1. The effect of endogenous dopamine in rotenone-induced toxicity in PC12 cells.
    Dukes AA; Korwek KM; Hastings TG
    Antioxid Redox Signal; 2005; 7(5-6):630-8. PubMed ID: 15890007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotenone-induced PC12 cell toxicity is caused by oxidative stress resulting from altered dopamine metabolism.
    Sai Y; Wu Q; Le W; Ye F; Li Y; Dong Z
    Toxicol In Vitro; 2008 Sep; 22(6):1461-8. PubMed ID: 18579341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of iptakalim on rotenone-induced cytotoxicity and dopamine release from PC12 cells.
    Yang Y; Liu X; Ding JH; Sun J; Long Y; Wang F; Yao HH; Hu G
    Neurosci Lett; 2004 Aug; 366(1):53-7. PubMed ID: 15265589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotenone induces KATP channel opening in PC12 cells in association with the expression of tyrosine hydroxylase.
    Bai Q; He J; Qiu J; Wang Y; Wang S; Xiu Y; Yu C
    Oncol Rep; 2012 Oct; 28(4):1376-84. PubMed ID: 22895566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis.
    Klintworth H; Newhouse K; Li T; Choi WS; Faigle R; Xia Z
    Toxicol Sci; 2007 May; 97(1):149-62. PubMed ID: 17324951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular dopamine oxidation mediates rotenone-induced apoptosis in PC12 cells.
    Liu HQ; Zhu XZ; Weng EQ
    Acta Pharmacol Sin; 2005 Jan; 26(1):17-26. PubMed ID: 15659109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine is involved in selectivity of dopaminergic neuronal death by rotenone.
    Sakka N; Sawada H; Izumi Y; Kume T; Katsuki H; Kaneko S; Shimohama S; Akaike A
    Neuroreport; 2003 Dec; 14(18):2425-8. PubMed ID: 14663204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p38(MAPK)/p53-Mediated Bax induction contributes to neurons degeneration in rotenone-induced cellular and rat models of Parkinson's disease.
    Wu F; Wang Z; Gu JH; Ge JB; Liang ZQ; Qin ZH
    Neurochem Int; 2013 Sep; 63(3):133-40. PubMed ID: 23714208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone.
    Nesti C; Pardini C; Barachini S; D'Alessandro D; Siciliano G; Murri L; Petrini M; Vaglini F
    Brain Res; 2011 Jan; 1367():94-102. PubMed ID: 20854799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of dopamine DA-D2 receptor in rotenone-induced cytotoxicity in PC12 cells.
    Siddiqui MA; Kashyap MP; Khanna VK; Yadav S; Al-Khedhairy AA; Musarrat J; Pant AB
    Toxicol Ind Health; 2010 Sep; 26(8):533-42. PubMed ID: 20634262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotenone and CCCP inhibit tyrosine hydroxylation in rat striatal tissue slices.
    Hirata Y; Nagatsu T
    Toxicology; 2005 Dec; 216(1):9-14. PubMed ID: 16115719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally.
    Ling Z; Chang QA; Tong CW; Leurgans SE; Lipton JW; Carvey PM
    Exp Neurol; 2004 Dec; 190(2):373-83. PubMed ID: 15530876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of dopamine transporter in selective toxicity of manganese and rotenone.
    Hirata Y; Suzuno H; Tsuruta T; Oh-hashi K; Kiuchi K
    Toxicology; 2008 Feb; 244(2-3):249-56. PubMed ID: 18206288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous dopamine is involved in the herbicide paraquat-induced dopaminergic cell death.
    Izumi Y; Ezumi M; Takada-Takatori Y; Akaike A; Kume T
    Toxicol Sci; 2014 Jun; 139(2):466-78. PubMed ID: 24743698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine hydroxylase-positive amacrine interneurons in the mouse retina are resistant against the application of various parkinsonian toxins.
    Nagel F; Bähr M; Dietz GP
    Brain Res Bull; 2009 Jun; 79(5):303-9. PubMed ID: 19406215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiating effect of the ATP-sensitive potassium channel blocker glibenclamide on complex I inhibitor neurotoxicity in vitro and in vivo.
    Kou J; Klorig DC; Bloomquist JR
    Neurotoxicology; 2006 Sep; 27(5):826-34. PubMed ID: 16725203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
    Takeuchi H; Yanagida T; Inden M; Takata K; Kitamura Y; Yamakawa K; Sawada H; Izumi Y; Yamamoto N; Kihara T; Uemura K; Inoue H; Taniguchi T; Akaike A; Takahashi R; Shimohama S
    J Neurosci Res; 2009 Feb; 87(2):576-85. PubMed ID: 18803299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by alpha-synuclein.
    Park SS; Schulz EM; Lee D
    Eur J Neurosci; 2007 Dec; 26(11):3104-12. PubMed ID: 18005066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells.
    Lamensdorf I; Eisenhofer G; Harvey-White J; Nechustan A; Kirk K; Kopin IJ
    Brain Res; 2000 Jun; 868(2):191-201. PubMed ID: 10854571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease.
    Saravanan KS; Sindhu KM; Mohanakumar KP
    Brain Res; 2005 Jul; 1049(2):147-55. PubMed ID: 15936733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.